#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Blastic plasmacytoid dendritic cell neoplasia Oropharyngeal cancer recurrent Pleural mesothelioma malignant Selective polysaccharide antibody deficiency Congenital disorder of glycosylation Retinitis pigmentosa Vulval cancer recurrent Pericarditis Myocarditis Wiskott-Aldrich syndrome Leiomyosarcoma Anti-myelin-associated glycoprotein associated polyneuropathy Niemann-Pick disease Leukocyte adhesion deficiency Dilated cardiomyopathy More trials…

    Learn about Rare Diseases

    Methylmalonic acidaemia – Trials in Disease Leiomyosarcoma recurrent – Basic Information Synovial sarcoma – Life with Disease Urea cycle disorder – Life with Disease Fabry’s disease – Trials in Disease Congenital nephrogenic diabetes insipidus – Treatment Breast angiosarcoma Erdheim-Chester disease – Life with Disease Cytokine release syndrome – Treatment Hepatoblastoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Setmelanotide Dexketoprofen Human Cancellous Bone Budesonide Tamsulosin Hydrochloride Calcium Fluoxetine Daunorubicin Hydrochloride Piromelatine Cemdisiran DAPIGLUTIDE Ketamine Pilocarpine Hydrochloride Sodium Phosphate Mezigdomide 6QC-ICG Osteodex [18F]Alf-Nota-Octreotide Bms-986315 Ursodeoxycholic Acid More therapies…

    Learn about Your Condition

    Hodgkin's disease recurrent Large cell lung cancer Carcinoid syndrome Hepatocellular carcinoma Cholangitis sclerosing Thrombolysis Iron deficiency Cataract Double hit lymphoma Toxic nodular goitre Cancer pain Ejection fraction normal Cardiac ventricular thrombosis Herpes simplex Endometrial cancer stage II More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • A study to compare continuous infusion and intermittent injections of furosemide and amiloride hydrochloride in patients hospitalized with acute heart failure and fluid overload

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac failure acute
    Investigated Drugs:
    • Amiloride Hydrochloride
    • Furosemide
    Denmark

  • Study of K-924 (ezetimibe and pitavastatin) in patients with high cholesterol who have an inadequate response to pitavastatin

    Recruiting

    3 1 1
    Investigated Diseases:
    • Hypercholesterolaemia
    Investigated Drugs:
    • Ezetimibe
    Spain

  • A study of PM54 and pembrolizumab in adults with advanced cancer

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Neoplasm malignant
    Investigated Drugs:
    • Pembrolizumab
    Italy Spain

  • A study using [11C]ORM-13070 to examine the effects of aging and Parkinson’s disease on specific brain receptors.

    Recruiting

    2 1 1
    Investigated Drugs:
    • 1-[[(3S)-2,3-DIHYDRO-1,4-BENZODIOXIN-3-YL]METHYL]-4-[3-((11C)METHOXYMETHYL)-2-PYRIDINYL]PIPERAZINE
    France

  • A study to evaluate the effect of CX11 trometamol monohydrate in patients with type 2 diabetes

    Recruiting

    2 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Poland

  • A study to evaluate the efficacy and safety of obinutuzumab compared to prednisolone in adults with newly onset minimal change disease

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Nephropathy
    Investigated Drugs:
    • Obinutuzumab
    • Tacrolimus
    • Betamethasone Sodium Phosphate
    Austria France Germany
Previous Page
1 … 24 25 26 27 28 … 1,645
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!